Abstract:Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Cariplo Foundation PRIN (Italian Ministry of University and Research) Aim Balance of cellular metabolism is increasingly recognized as a hallmark of physiologic cellular functions; this also extends to cells of the immune system. Here, we aimed at investigating the role of SREBP1c, a key protein regulating intracellular fatty acid (FA) metabolism, on the metabolism and function of Treg, that play a key role in immune tolerance maintenance. Material and Methods A detailed immunophenotyping through flow cytometry and metabolic profiling (metabolomics and seahorse analysis) of isolated Tregulatory (CD4+CD25+, nTreg) and in vitro induced Treg (iTreg) cells were performed together with in vitro and in vivo assays of Treg function from SREBP1c KO and WT littermates. RNAseq and lipidomics was performed on iTreg. Results Srebp1c deficiency reduced suppressive (-21%,p<0,01) and increased migratory function (+40%,p<0,05) of nTreg and iTreg, tested by in vitro assays. In vivo, Srebp1c KO mice presented reduced circulating and tissues' level of Treg compared to WT mice (-66%,p<0,01) and nTreg from Srebp1c KO mice worsened Experimental Autoimmune Encephalomyelitis progression compared to WT nTreg. We addressed impaired Treg function to metabolic alteration due to Srebp1c deficiency: KO iTreg showed an increased glycolytic potential with preserved mitochondrial function coupled to accumulation of glycolytic metabolites and lactate (+20%,p<0,01) and reduced energy charge (-40%,p<0.01). We associated the switch to anaerobic glycolysis in KO Treg to an impaired lipid metabolism, as suggested by impaired abundance of lipid species (TG, LPC and PC); this was confirmed by RNAseq showing a downregulation of lipid metabolism's pathways and upregulation of glycolysis. In parallel, tolerogenic response was impaired, a phenotype associated to a reduced transcription and activation of Foxp3, the master regulator of Treg function. Conclusion By restrain glycolysis and preserving lipid metabolism, our data have identified SREBP1c as a checkpoint crucial for the immunometabolic suppressive response of Tregs.

The Receptor S1P1 Overrides Regulatory T Cell–mediated Immune Suppression Through Akt-mTOR

TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses Through a Noncytotoxic Mechanism

The S1P 1 -mTOR axis directs the reciprocal differentiation of T H 1 and T reg cells

Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity.

S1PR1 inhibition induces proapoptotic signaling in T cells and limits humoral responses within lymph nodes

S1P1 deletion differentially affects TH17 and Regulatory T cells

Sphingosine 1‐phosphate Combining with S1PR4 Promotes Regulatory T Cell Differentiation Related to FAO Through Nrf2/PPARα

T Cell Signaling Targets for Enhancing Regulatory or Effector Function.

The sterol element binding protein 1c (SREBP1c) preserves cellular metabolism and immunosuppressive function of regulatory t cells

S1p(1) Receptor Expression Regulates Emergence of Nkt Cells in Peripheral Tissues

Program Death-1 Regulates Peripheral T Cell Tolerance Via an Anergy-Independent Mechanism

Sphingosine 1 Phosphate Receptor-1 (S1P1) Promotes Tumor-Associated Regulatory T Cell Expansion: Leading to Poor Survival in Bladder Cancer.

TSC 1 Regulates the Balance Between Effector and Regulatory T Cells

SHIP-1 Regulates the Differentiation and Function of Tregs via Inhibiting mTORC1 Activity

Nutrient Mtorc1 Signaling Underpins Regulatory T Cell Control of Immune Tolerance

Sphingosine-1-phosphate signaling inhibition suppresses Th1-like Treg generation by reversing mitochondrial uncoupling

Precise Spatiotemporal Interruption of Regulatory T-cell-Mediated CD8(+) T-cell Suppression Leads to Tumor Immunity

Sphingosine‐1‐Phosphate Signalling Inhibition Suppresses Th1‐Like Treg Generation by Reversing Mitochondrial Uncoupling

PPARδ restrains the suppression function of intra-tumoral Tregs by limiting CIITA-MHC II expression

Regulatory T cells control type 1-driven immunopathology restraining GM-CSF-producing helper T cells

Histone Deacetylase SIRT1 Negatively Regulates the Differentiation of Interleukin-9-Producing CD4(+) T Cells.